Tag: university

Communication Service for the Deaf Appoints Karen Peltz Strauss to Board of Directors

AUSTIN, Texas, June 4, 2026 /PRNewswire/ -- Communication Service for the Deaf (CSD) announced today that it has appointed Karen Peltz Strauss to its...

Northeastern University Unveils GENESIS: First Agentic AI System to Take 5G/6G RAN Features from Specification to Over-the-Air in Hours

BOSTON, June 4, 2026 /PRNewswire/ -- Researchers at Northeastern University's Institute for Intelligent Networked Systems (INSI) have developed GENESIS, an agentic AI framework that automates...

NATIONAL KIDNEY REGISTRY LAUNCHES REVOLUTIONARY TRANSPORT CONTAINER FOR KIDNEYS

GREENWICH, Conn., June 4, 2026 /PRNewswire/ -- National Kidney Registry (NKR) is pleased to announce the nationwide rollout of the StrongBox®. The StrongBox® is a...

Centre for Neuro Skills’ Chris Persel Receives First-Ever Enduring Contributions Award

Chris Persel of Centre for Neuro Skills receives the first-ever Enduring Contributions Award from ABAI's Brain Injury Special Interest Group.

Tishman Speyer Secures $300 Million First Close for Korea Living Venture with APG and Bouwinvest

European Pension Investors Back Strategy Focused on Korea's Rapidly Expanding Rental Housing MarketNEW YORK, June 4, 2026 /PRNewswire/ -- Tishman Speyer today announced the...

Drucker + Falk Promotes Key Leaders to Chief People Officer and Chief of Staff Roles

Drucker + Falk expands executive team, promoting Amber Kirby to Chief People Officer and Tarra Secrest to Chief of Staff to support strategic growth.

BREAKING NEWS: CHG EnSOL Launches AIDC PV Modules

SHANGHAI, June 4, 2026 /PRNewswire/ -- On June 3, the 19th (2026) International Photovoltaic Power Generation and Smart Energy Conference & Exhibition grandly opened...

Option Care Health Appoints Robert Okunski as Vice President, Investor Relations

BANNOCKBURN, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced the appointment of Robert Okunski as Vice President, Investor Relations effective May 26, 2026.

AbolerIS Pharma Presents New Data Supporting CD45RC as a Novel Therapeutic Target and Potential Biomarker in Sjögren’s Disease at EULAR 2026

- Findings demonstrate strong correlation between CD45RC expression and lymphocytic infiltration in salivary glands, supporting its potential as both an early biomarker and therapeutic...

【COMPUTEX 2026】Compal Integrates Quantum Technology and AI – Partnering with Top Universities and Pharmaceutical Firms to Build a Biotech AI Platform

TAIPEI, June 4, 2026 /PRNewswire/ -- Compal Electronics (Compal; TWSE: 2324) showcases its landmark achievements in Quantum Technology and Advanced Artificial Intelligence (AI) at COMPUTEX...

Orion Innovation and Amrita University Launch Applied GenAI Elective Program to Prepare Students for AI-Driven Careers

Industry-academia collaboration brings hands-on AI learning and real-world technology exposure to students across three campusesCOIMBATORE, India, June 4, 2026 /PRNewswire/ -- Orion Innovation ("Orion"), a...

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).

2026 ASCO LBA | Juncell Therapeutics’ GC101 TIL Therapy Achieves Primary Endpoint in the Pivotal Phase II Trial for PD-1 Antibody Failed Advanced Melanoma

SHANGHAI, June 3, 2026 /PRNewswire/ -- On June 1 (Chicago time), in a Late-Breaking Abstract (LBA) oral presentation at the 2026 American Society of Clinical...

POP Biotechnologies Secures Up to $9.7 Million in CEPI Funding

Funding to Propel POP BIO SNAP™ Nanoparticle Vaccine Platform into Phase 1 Clinical Trials in the U.S.

Funding to Propel POP BIO SNAP™ Nanoparticle Vaccine Platform into Phase 1 Clinical Trials in the U.S.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsUniversity

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option

Arctic Gateway Group and Aecon sign collaboration agreement to support Port of Churchill infrastructure advancement in Manitoba

BADGER METER INVESTOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Badger Meter, Inc. and Encourages...